Self assessment is interesting topic.My robust discussion to you...

Self assessment is interesting topic.
My robust discussion to you is "what you think you are doing, and what you are actually doing, are two different things".

You proclaim to offer alternate views. Nothing wrong with that.

However IMO you have only ever had one alternate view.
Should Dr T use HC as a platform to give guidance on a very technical topic and make comment.

Dr T uses HC and many other social media platforms.
...and it has been stated many a time by Dr T that it is an efficient tool to use.
...and Dr T declares who he is on HC.
Clearly HC and the ASX have no issue with this either.

As a self declared non-holder, it is hard to ignore that your only here with an agenda.
You might say you are helping people.
Most investors here are saying, we heard you and we disagree, so go away.
Something I expect you may refute.
But why else be here with your 17,000 plus posts.
It is certainly not wisdom you are sharing.

90% of your posts relate to this one topic of Dr T using HC and not the question really at hand.
Can Bisantrene make a huge difference to cancer sufferers?
The investors here are say it can and will.
Yes, there are risks as there always is.
However, the form guide on Bisantrene is less speculative than the horse races
What do you say?

If you actually offered different views I would be somewhat interested.
Your posts are typically positioned as questions and have been on this repetitive topic for many years.
It seems you have difficulty listening and understanding what you have been advised all those years.
I note that when you are advised of facts you seem to have selective hearing.
i.e. no comments on the specifics of Bisantrene just generalised commentry on biotech trial processes and their risks. It might be nice if you actually provide some commentry on the difference between the chance of success of Bisantrene, a previously approved molecule with positive results (has form), versus a completely new molecule under trial with no previous results trying to make it. I'd be interested in your alternate view.

BTW the facts are that less than 3% of new molecules make it, yet Bisantrene whilst considered a new molecule is an 80% chance. Interestingly, Bisantrene made it some 35 years ago but failed to commercialise for a variety of reasons, namely ease of delivery. What say you on that?

I look forward to your robust answers.

Merry Christmas all.